Predictive Role of sTREM in Endovascular Thrombectomy Outcomes

Recruiting now

Conditions studied: Acute Ischemic Stroke

In brief

Soluble triggering receptor expressed on myeloid cells (sTREM), which reflects microglia activation, has been reported closely associated with neuronal injury and neuroinflammation. This study is to investigatethe prognostic roles of sTREM (sTREM1 and sTREM2) in patients with ischemic stroke who underwent endovascular thrombectomy (EVT).

Key facts

Study ID

NCT06545591

Run by

The Affiliated Hospital of Xuzhou Medical University

People needed

300

Starts

2024-07-01

Expected to finish

2027-12-31

Last updated by the study team

2024-08-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients > 18 years old.
• Patients with acute large vessel occlusion within 24 hours of onset who will receive endovascular treatment.

You may not qualify if…

• Impossibility of getting a blood sample.
• Impossibility of performing the test (Invalid results).
• Refusal to provide the informed consent by the patient/relative.

Where it is running

• Department of Neurology — Xuzhou, Jiangsu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.